Christoph Bieri |

Christoph Bieri, PhD is Managing Partner of Kurmann Partners www.kurmannpartners.com, an M&A firm advising Pharma and MedTech companies on strategic mid-market deals in Europe and the Americas. Mr. Bieri has extensive experience in leading complex transactions, both as a buy-side and sell-side advisor, and regularly presents and publishes analyses of drivers of M&A in the life science industries.

Prior to joining Kurmann Partners, Christoph was founder and CEO of a drug discovery technology company, and before that a senior associate with The Boston Consulting Group. He holds a PhD in Biophysics from ETH Lausanne and a Master in Biochemistry from the Biocenter of the University of Basel.